LeonaBio

LONANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$72.142 M

$7.68 -1.67%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$106.0M

Loss-making

Shares outstanding

9,393,514

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#116Cardiff OncologyCRDF$77.2M
#117Atara BiotherapeuticsATRA$76.1M
#118LeonaBioLONA$72.1M
#119Champions OncologyCSBR$72.1M
#120Eloxx PharmaceuticalsELOX$70.9M

Where these numbers come from

Share counts and financials for LeonaBio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.